Legal explainer · from the 250-topic plan
The informed-consent teardown: eight clauses every compounded-GLP-1 consent must contain
The consent document is where a telehealth program confesses what it actually is — and most patients scroll past it in four seconds. Read properly, a compounded-GLP-1 consent must contain eight findable clauses: the compounded, not-FDA-approved statement in plain words; the material risks including the thyroid C-cell boxed-warning content and the MTC/MEN2 contraindication; the alternatives, including the approved brands; the telehealth modality's limits; the clinical relationship's identity; side-effect instructions and emergency routing; the cost-and-billing cross-reference; and your withdrawal rights. This teardown gives you the eight-clause checklist, the placement red flags (consent after payment is a confession of its own), and the two things no signature ever waives.
What consent legally does
Informed consent isn't a liability shield the program aims at you; it's a legal duty the program owes you — evidence that a real clinician disclosed what a reasonable patient needs to decide: diagnosis-relevant facts, material risks, benefits, alternatives, and the option to decline. In the compounded lane the duty grows a specific tooth: several state actions in this industry have turned on consents that omitted or buried the compounded status — which is why clause one below is the whole document's keystone, and why layer three of the legal stack got its own article.
The eight clauses, findable in order
1 — The compounded statement: plain words that the product is compounded and not FDA-approved, not euphemized as “personalized” or “pharmacy-crafted.” If you can't find this sentence, stop scrolling and stop shopping. 2 — Material risks, named: the class GI profile, gallbladder and pancreatitis risks, and the boxed-warning content — rodent thyroid C-cell tumors, with the contraindication for personal/family history of medullary thyroid carcinoma or MEN2 — asked about in screening, not merely disclaimed. 3 — Alternatives: the approved products (Wegovy, Zepbound, and their pathways) plus non-drug options; consent to a compounded product chosen in ignorance of the approved ones isn't informed. 4 — Telehealth limits: what remote care can and can't assess, and when in-person care is required. 5 — The relationship: which clinical entity is treating you — the corporate-practice architecture made visible. 6 — Instructions and emergencies: what symptoms end the experiment and where to route them. 7 — The money cross-reference: billing terms incorporated or linked — consent and checkout describing the same reality. 8 — Withdrawal: your right to stop treatment and what stopping involves. Eight clauses, five minutes, one Ctrl-F session.
Placement red flags
Where consent lives tells you what it's for. Consent after payment — the document appearing only post-checkout — inverts the entire concept. The pre-checked box — consent as default state — is the classic express-consent failure. The unreadable modal — no download, no print, vanishing after signature — defeats the record-keeping that protects you; save a copy of anything you sign, because versions change and yours is the one that governs. The signature race — countdown timers adjacent to medical consent — imports flag 10's urgency machinery into the one document urgency should never touch.
What signing never waives
Two limits worth knowing before the scribble. First, courts are broadly hostile to waivers of professional negligence — a consent form describing risks is not a permission slip for substandard care, and “you signed” is not a defense to malpractice. Second, consent doesn't waive consumer-protection law: deceptive pricing, unauthorized billing, and the negative-option rules operate regardless of any agreement's enthusiasm. Signing a good consent is informed medicine; signing a bad one is evidence — either way, the document works for the patient who actually read it, which as of this paragraph is you. The benchmark standard this site scores against treats the compounded statement as above-the-fold content, not fine print — the difference between disclosure as duty and disclosure as burial. Disclosure done above the fold ↗
FAQ
What must a compounded GLP-1 consent form include?
Eight findable clauses: the plain-words compounded/not-FDA-approved statement, material risks including boxed-warning and MTC/MEN2 content, alternatives including approved brands, telehealth limits, the treating clinical entity, symptom/emergency instructions, billing cross-reference, and withdrawal rights.
Is consent shown after payment valid?
It's a structural red flag — informed consent is supposed to precede the decision; post-checkout consent inverts the concept and signals how the program ranks your understanding.
Does signing a consent waive my right to sue?
Not for professional negligence — courts broadly refuse such waivers — and never for consumer-protection violations like deceptive pricing or unauthorized billing.
Should I keep a copy?
Always — download or print the version you signed; terms change, and the version bearing your signature is the one that governs your care and any dispute.
Sources
- State informed-consent doctrines and telehealth consent statutes.
- Boxed-warning and contraindication language — Zepbound/Wegovy prescribing information.
- State enforcement actions involving compounded-status disclosure failures.
- ROSCA and consumer-protection interplay — companion analysis on this site.